JAGX:NASDAQJaguar Health, Inc. analysis
Data as of Sep 24, 2026 - not real-time
- Latest price
- $8.91
- Risk: high
- 9/10High risk
Summary
Jaguar Health, Inc. is priced at $8.91 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has lost 24.1%. With RSI at 48.5 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $2.35 up to resistance at $41.53.
The shares look fair, trading on 0.0 times earnings below a sector average of 30.2. Revenue is contracting at 58.9% on a -130.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 874.8%, a beta of 2.60 and a maximum drawdown of 99.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to sell, carrying 5/10 conviction.
The shares look fair, trading on 0.0 times earnings below a sector average of 30.2. Revenue is contracting at 58.9% on a -130.8% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 874.8%, a beta of 2.60 and a maximum drawdown of 99.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to sell, carrying 5/10 conviction.
Top market events
- Jaguar Health aims to file for approval of its Crofelemer powder treatment for pediatric MVID in mid-2027.
- Jaguar Health JAGX stock fell 28% premarket Wednesday after Tuesday's 1,190% rally sparked by FDA fee waivers and...
- Jaguar Health JAGX is up 1585.4% today. Here is some analysis on what might have caused this price
Market outlook
Short term
< 1 yearCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 197.02
- MACD momentum is positive
Medium term
1–3 yearsCautious
Model confidence4/104 out of 10
Key factors
- Short-term moving averages stacked below long-term ones
- P/E of 0.0 versus sector average of 30.2
- Trading below the 200-day average of 197.02
Long term
> 3 yearsCautious
Model confidence5/105 out of 10
Key factors
- P/E of 0.0 versus sector average of 30.2
- Negative profit margin of -130.8%
- Negative return on equity of -548.8%
Key metrics
Financial health
Revenue Growth-58.90%
Profit Margin-130.85%
P/E Ratio0.0
ROE-548.83%
ROA-38.04%
Debt/Equity253.29
P/B Ratio6.5
Op. Cash Flow$-6685000
Free Cash Flow$-1778125
Industry P/E30.2
Technical analysis
TrendBearish
RSI48.5
Support$2.35
Resistance$41.53
MA 20$8.82
MA 50$12.76
MA 200$197.02
MACDBullish
VolumeIncreasing
Fear & Greed Index92.73
Valuation
GradeFair
TypeBlend
Risk assessment
Beta2.60
Volatility874.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.